Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Diagnosis of asthma in adolescents and adults

Christopher H Fanta, MD
Section Editors
Peter J Barnes, DM, DSc, FRCP, FRS
Bruce S Bochner, MD
Deputy Editor
Helen Hollingsworth, MD


The "classic" signs and symptoms of asthma are intermittent dyspnea, cough, and wheezing. Although typical of asthma, these symptoms are nonspecific, making it sometimes difficult to distinguish asthma from other respiratory diseases. The definitive diagnosis of asthma requires the history or presence of respiratory symptoms consistent with asthma, combined with the demonstration of variable expiratory airflow obstruction [1,2].

Tools used in the diagnosis of asthma include history, physical examination, pulmonary function testing, and other laboratory evaluations. This topic review describes these tools, followed by several specific strategies for making the diagnosis of asthma in adolescents and adults.

The diagnosis of asthma in children and older adults and an overview of asthma management are discussed separately. (See "Asthma in children younger than 12 years: Initial evaluation and diagnosis" and "Diagnosis and management of asthma in older adults" and "An overview of asthma management".)


While asthma is readily recognized in its classic presentation, with intermittent cough, wheeze, and shortness of breath brought on by characteristic triggers and relieved by bronchodilating medications, it is difficult to provide a definition that distinguishes asthma from similar and overlapping conditions. In the absence of a definitive laboratory test or biomarker, asthma has defied precise definition, one acceptable to all disciplines (including clinicians, physiologists, and pathologists). Clinically, its symptoms are non-specific. Physiologically, asthma is characterized by bronchial hyperresponsiveness, the tendency of airways to narrow excessively in response to a variety of stimuli that provoke little or no bronchoconstriction in persons without airway disease, but bronchial hyperresponsiveness is not unique to asthma. Pathologically, asthma may be described broadly as "a chronic inflammatory disorder of the airways" [1]. However, this description omits the characteristic waxing and waning of airflow obstruction in asthma and fails to distinguish asthma from other inflammatory airways disorders, such as chronic bronchitis or bronchiolitis.

A more precise definition combines the central roles of inflammation and bronchial hyperresponsiveness with the characteristic clinical symptoms. Towards this end, asthma has been defined by the Expert Panel 3 of the National Asthma Education and Prevention Program as "a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation. The interaction of these features of asthma determines the clinical manifestations and severity of asthma and the response to treatment" [1]. This definition is descriptive of key features of the disease, but it lacks utility for patients and clinicians.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Mar 24, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on December 04, 2014).
  2. Global Initiative for Asthma. Global strategy for asthma management and prevention (Updated 2015). http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11.pdf (Accessed on March 01, 2016).
  3. Fahy JV, O'Byrne PM. "Reactive airways disease". A lazy term of uncertain meaning that should be abandoned. Am J Respir Crit Care Med 2001; 163:822.
  4. Yunginger JW, Reed CE, O'Connell EJ, et al. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis 1992; 146:888.
  5. Pratter MR, Hingston DM, Irwin RS. Diagnosis of bronchial asthma by clinical evaluation. An unreliable method. Chest 1983; 84:42.
  6. Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141:640.
  7. Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989; 149:2277.
  8. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med 2014; 370:640.
  9. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319.
  10. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948.
  11. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Revised 2011. Global Initiative for Chronic Obstructive Lung Disease (GOLD). www.goldcopd.org (Accessed onSeptember 10, 2012).
  12. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. Asthma outcome. Am J Respir Crit Care Med 1994; 149:S9.
  13. Irvin, CG, Eidelman, D. Airways mechanics in asthma. In: Rhinitis and Asthma, Holgate, S, Busse, W (Eds), Blackwell Scientific Publications, Boston 1995.
  14. U.S. Department of Health and Human Services. International consensus report on diagnosis and treatment of asthma. U.S. Government Printing Office, Washington D.C. PHHS Publication No. 92-3091, 1992.
  15. Smith HR, Irvin CG, Cherniack RM. The utility of spirometry in the diagnosis of reversible airways obstruction. Chest 1992; 101:1577.
  16. Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179:1121.
  17. Aguilar-Fernández AJ, Villa-Asensi JR, Castro-Codesal M, et al. Concordance between the Piko - 1 portable device and pneumotachography in measuring PEF and FEV(1) in asthmatic children. Allergol Immunopathol (Madr) 2009; 37:244.
  18. Solomon DA, Fanta CH, Levy BD, Loscalzo J. Clinical problem-solving. Whistling in the dark. N Engl J Med 2012; 366:1725.
  19. Scott S, Currie J, Albert P, et al. Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma. Chest 2012; 141:616.
  20. Postma DS, Rabe KF. The Asthma-COPD Overlap Syndrome. N Engl J Med 2015; 373:1241.
  21. Gaugris S, Sazonov-Kocevar V, Thomas M. Burden of concomitant allergic rhinitis in adults with asthma. J Asthma 2006; 43:1.
  22. Meltzer EO. The relationships of rhinitis and asthma. Allergy Asthma Proc 2005; 26:336.